Featured News Archives - Healing Genes

Celgene posts pivotal CAR-T data ahead of FDA filing

Celgene has posted data from a pivotal trial of its CAR-T therapy. The data look competitive against Gilead’s Yescarta and Novartis’ Kymriah, leading analysts to predict Celgene will win FDA approval next year. Investigators administered lisocabtagene maraleucel (liso-cel), an anti-CD19 CAR-T, to 262 patients with large...

CRISPR-Cas9, IRBM, GenScript, and More: News From September 2019

September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including CRISPR-Cas9, IRBM,GenScript, and more. The US Patent and Trademark Office (USPTO) awarded a new CRISPR-Cas9 patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering compositions of single...